STEM Times of Connecticut: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times of Connecticut.

Press releases published on October 15, 2026

Oct. 15, 2026

Seventh Annual AutoTech Breakthrough Awards Program Honors the Companies Transforming How the World Moves

Indeterminate GlobeNewswire

Oct. 15, 2026

Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer

Indeterminate GlobeNewswire

Oct. 15, 2026

First Tracks Biotherapeutics Announces $200 Million Private Placement

Indeterminate GlobeNewswire

Oct. 15, 2026

Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates

Indeterminate GlobeNewswire

Oct. 15, 2026

Fusemachines Unveils HireFoundry.ai, Evolving from a Single Interview Agent to a Growing Platform of AI Agents for Enterprise Hiring

Indeterminate GlobeNewswire

Oct. 15, 2026

Crane NXT Announces Dates for Third Quarter 2026 Earnings Release and Earnings Call

Indeterminate GlobeNewswire

Oct. 15, 2026

EverCommerce Announces Date of Third Quarter 2026 Earnings Call

Indeterminate GlobeNewswire

Oct. 15, 2026

IMPAUER TECHNOLOGIES ANNOUNCES COMMERCIAL LAUNCH OF PAUERONE WALLET V1 ACROSS ANDROID, WEB, AND BROWSER EXTENSION

Indeterminate GlobeNewswire

Oct. 15, 2026

SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies

Indeterminate GlobeNewswire

Oct. 15, 2026

Salvia BioElectronics Initiates Pivotal Study with First Patient in the U.S. Receiving Ultra Thin Neuromodulation Implant for Resistant Migraine

Indeterminate GlobeNewswire

Oct. 15, 2026

Eindhovens medtechbedrijf Salvia BioElectronics start grootschalige studie in de VS met flinterdunne implantaten tegen migraine

Indeterminate GlobeNewswire

Oct. 15, 2026

R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026

Indeterminate GlobeNewswire

Oct. 15, 2026

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

Indeterminate GlobeNewswire

Oct. 15, 2026

illumin Holdings Inc. announces date for third quarter 2026 financial and operating results

Indeterminate GlobeNewswire

Oct. 15, 2026

Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire

Oct. 15, 2026

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026

Indeterminate GlobeNewswire

Oct. 15, 2026

Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

Oct. 15, 2026

Certiverse Launches Self-Starter Subscriptions, Cutting the Cost of Certification by 80% as AI Reshapes the Skills Employers Need to Verify

Indeterminate GlobeNewswire

Oct. 15, 2026

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

Indeterminate GlobeNewswire

Oct. 15, 2026

Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome

Indeterminate GlobeNewswire